US FDA extends review of Rhythm Pharma's drug for rare form of obesity

reuters.com/business/healthcare-pharmaceuticals/us-fda-extends-review-rhythm-pharmas-drug-rare-form-obesity-2025-11-07

This story appeared on reuters.com, 2025-11-07 12:45:48.209000.
The Entire Business World on a Single Page. Free to Use →